Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Late-Onset ADHD: Case Closed or Open Question?

Agnew-Blais J, Arseneault L.

Am J Psychiatry. 2018 May 1;175(5):481-482. doi: 10.1176/appi.ajp.2018.17111240. No abstract available.

PMID:
29712480
2.

Psychiatric comorbidities of adults with early- and late-onset attention-deficit/hyperactivity disorder.

Lin YJ, Yang LK, Gau SS.

Aust N Z J Psychiatry. 2016 Jun;50(6):548-56. doi: 10.1177/0004867415609423. Epub 2015 Oct 12.

PMID:
26460330
3.

Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11.

Todd RD, Huang H, Henderson CA.

J Child Psychol Psychiatry. 2008 Sep;49(9):942-9. doi: 10.1111/j.1469-7610.2008.01892.x. Epub 2008 Jun 28.

PMID:
18564071
4.

Comment on Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25.

Chamberlain SR, Müller U.

Am J Psychiatry. 2018 May 1;175(5):480. doi: 10.1176/appi.ajp.2018.17121308. No abstract available.

5.

Validation of DSM-5 age-of-onset criterion of attention deficit/hyperactivity disorder (ADHD) in adults: Comparison of life quality, functional impairment, and family function.

Lin YJ, Lo KW, Yang LK, Gau SS.

Res Dev Disabil. 2015 Dec;47:48-60. doi: 10.1016/j.ridd.2015.07.026. Epub 2015 Aug 27.

PMID:
26318976
6.

Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder?

Reinhardt MC, Benetti L, Victor MM, Grevet EH, Belmonte-de-Abreu P, Faraone SV, Rohde LA.

J Clin Psychiatry. 2007 Jul;68(7):1109-16.

PMID:
17685750
7.

Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?

Faraone SV, Biederman J, Spencer T, Mick E, Murray K, Petty C, Adamson JJ, Monuteaux MC.

Am J Psychiatry. 2006 Oct;163(10):1720-9; quiz 1859.

PMID:
17012682
8.

Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome.

Caye A, Rocha TB, Anselmi L, Murray J, Menezes AM, Barros FC, Gonçalves H, Wehrmeister F, Jensen CM, Steinhausen HC, Swanson JM, Kieling C, Rohde LA.

JAMA Psychiatry. 2016 Jul 1;73(7):705-12. doi: 10.1001/jamapsychiatry.2016.0383.

9.

Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood.

Agnew-Blais JC, Polanczyk GV, Danese A, Wertz J, Moffitt TE, Arseneault L.

JAMA Psychiatry. 2016 Jul 1;73(7):713-20. doi: 10.1001/jamapsychiatry.2016.0465.

10.

Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses.

Faraone SV, Kunwar A, Adamson J, Biederman J.

Psychol Med. 2009 Apr;39(4):685-93. doi: 10.1017/S0033291708003917. Epub 2008 Jun 30.

11.

[DMS-5 - attention-deficit/hyperactivity disorder].

Banaschewski T, Döpfner M.

Z Kinder Jugendpsychiatr Psychother. 2014 Jul;42(4):271-5; quiz 276-7. doi: 10.1024/1422-4917/a000299. Review. German.

PMID:
25005904
12.

Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25.

Sibley MH, Rohde LA, Swanson JM, Hechtman LT, Molina BSG, Mitchell JT, Arnold LE, Caye A, Kennedy TM, Roy A, Stehli A; Multimodal Treatment Study of Children with ADHD (MTA) Cooperative Group.

Am J Psychiatry. 2018 Feb 1;175(2):140-149. doi: 10.1176/appi.ajp.2017.17030298. Epub 2017 Oct 20.

13.

An open-label trial of OROS methylphenidate in adults with late-onset ADHD.

Biederman J, Mick E, Spencer T, Surman C, Hammerness P, Doyle R, Dougherty M, Aleardi M, Schweitzer K.

CNS Spectr. 2006 May;11(5):390-6.

PMID:
16641844
14.

Against the status quo: revising the diagnostic criteria for ADHD.

Barkley RA.

J Am Acad Child Adolesc Psychiatry. 2010 Mar;49(3):205-7. No abstract available.

PMID:
20410708
15.

A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD.

Rydén E, Thase ME, Stråht D, Aberg-Wistedt A, Bejerot S, Landén M.

Acta Psychiatr Scand. 2009 Sep;120(3):239-46. doi: 10.1111/j.1600-0447.2009.01399.x. Epub 2009 May 7.

PMID:
19426162
16.

Symptom dimensions of attention deficit hyperactivity disorder and nicotine withdrawal symptoms.

Ameringer KJ, Leventhal AM.

J Addict Dis. 2012;31(4):363-75. doi: 10.1080/10550887.2012.735568.

17.

Impact of the DSM-5 attention-deficit/hyperactivity disorder age-of-onset criterion in the US adolescent population.

Vande Voort JL, He JP, Jameson ND, Merikangas KR.

J Am Acad Child Adolesc Psychiatry. 2014 Jul;53(7):736-44. doi: 10.1016/j.jaac.2014.03.005. Epub 2014 Apr 23.

PMID:
24954823
18.

Epidemiology of attention-deficit/hyperactivity disorder across the lifespan.

Polanczyk G, Rohde LA.

Curr Opin Psychiatry. 2007 Jul;20(4):386-92. Review.

PMID:
17551354
19.
20.

Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates.

Tamam L, Karakus G, Ozpoyraz N.

Eur Arch Psychiatry Clin Neurosci. 2008 Oct;258(7):385-93. doi: 10.1007/s00406-008-0807-x. Epub 2008 Apr 24.

PMID:
18437277

Supplemental Content

Support Center